3.7100
0.0000
(0.00%)
As of April 3 at 4:00:00 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 8 |
| Avg. Estimate | -- | -- | 128.32M | 165.53M |
| Low Estimate | -- | -- | 125.5M | 151.44M |
| High Estimate | -- | -- | 132.09M | 178.58M |
| Year Ago Sales | -- | -- | 89.54M | 128.32M |
| Sales Growth (year/est) | -- | -- | 43.31% | 29.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OXBDF | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Related Tickers
KAN.ST Kancera AB (publ)
1.1020
-1.61%
SCLP.L Scancell Holdings plc
8.15
0.00%
SNG.L Synairgen plc
0.9500
-9.52%
RNAC Cartesian Therapeutics, Inc.
10.41
-15.68%
RZLT Rezolute, Inc.
2.5800
-5.84%
INZY Inozyme Pharma, Inc.
0.8102
-7.46%
LXEO Lexeo Therapeutics, Inc.
2.3900
-9.47%
BCYC Bicycle Therapeutics plc
7.02
-5.52%
LRMR Larimar Therapeutics, Inc.
1.9300
-2.53%
MRVI Maravai LifeSciences Holdings, Inc.
1.9750
-5.95%